Kristin Abate serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Kristin Abate has executed 7 insider transactions totaling $5.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 21, 2026 involved selling 265 shares valued at $1.6K.
Kristin Abate currently holds 22,580 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristin Abate has been a net seller of KPTI stock. They have purchased $0 and sold $5.0K worth of shares.
Kristin Abate's most recent insider trade was on Jan 21, 2026, when they sold 265 shares at $5.96 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 1, 2025 | KPTI | $2.3K | Sale | 362 | $6.30 | Discretionary |
| Sep 15, 2025 | KPTI | $148 | Sale | 23 | $6.43 | Discretionary |
| Sep 12, 2025 | KPTI | $0 | Award | 46 | $N/A | Discretionary |
| Sep 3, 2025 | KPTI | $81 | Sale | 12 | $6.78 | Discretionary |
| Jul 22, 2025 | KPTI | $952 | Sale | 238 | $4.00 | Discretionary |